Clinical Trial Update: A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

This document outlines a Phase 1 clinical study of BioTTT001 in combination with toripalimab and regorafenib for metastatic colorectal cancer, sponsored by Chin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BioTTT001
• Stivarga (regorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: China Medical University, China | Conditions: Colorectal Cancer Metastatic | Phase 1 | Status: NOT_YET_RECRUITING